[1]
“Ameliorating the antitumor activity of lenalidomide using PLGA nanoparticles for the treatment of multiple myeloma”, Braz. J. Pharm. Sci., vol. 53, no. 2, p. e15185-, Jan. 2017, doi: 10.1590/s2175-97902017000215185.